Brain metastases: therapeutic options
Brain metastases: therapeutic options
The changing landscape of melanoma treatment
Immunosenescence and autoantibodies in ageing patients
The international myeloma working group frailty score for elderly patients with multiple myeloma
Osteoporosis and osteopenia in elderly patients
Breast cancer highlights from ESMO 2018
Keynote lecture: Mutation signatures and targeting the DNA damage response
Modern melanoma treatment in the UK
Highlights in early non-metastatic NSCLC and thoracic tumours
Combination strategies of immunotherapy in breast cancer
ABOUND.sqm: nab-paclitaxel and carboplatin induction followed by nab-paclitaxel maintenance in NSCLC
CheckMate142: Checkpoint combination therapy in first-line colorectal cancer